You searched for "simulator"
Evaluation of keratometry with a novel colour LED corneal topographer
The Cassini topographer (i-Optics), which analyses corneal shape based on the reconstruction of specular reflections on 679 coloured LEDs, generates keratometry and is the new machine being compared in this study with other keratometry devices. The prospective comparative study included...
Detection of post stroke visual impairment in variety of cohorts
1 December 2021
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Reproducible, Stroke, incidence, prevalence, vision
The Impact of Visual Impairment after Stroke (IVIS) study introduced a standardised vision assessment protocol across three acute stroke units in the northwest of England, with a similar demographic population (predominantly white British). The study reported similar rates of visual...
Outcomes for strabismus surgery dependent on access to insurance
The primary aim of this study was to compare postoperative outcomes in a larger cohort of paediatric patients having strabismus surgery with at least 11 months follow-up to determine the impact of low socio-economic status (SES) and health disparities and...
The incidence of retinal vein occlusion in patients with pseudoexfoliation glaucoma
1 June 2019
| Sofia Rokerya
|
EYE - Glaucoma
In this retrospective study the authors aimed to evaluate PXF as an independent risk factor for the occurrence of retinal vein occlusion (RVO). Three hundred PXF glaucoma patients (PXF group), 300 non-PXF glaucoma patients, and 599 non glaucoma non-PXF (nGnP...
The Case of Dr Bawa-Garba – Do we truly have a ‘no blame’ culture?
1 October 2018
| Amar Alwitry
|
EYE - General
Eye News’ medico-legal specialist shares his thoughts on the recent acquittal of Dr Bawa-Garba. On 13 August 2018 the Court of Appeal ruled that Dr Hadiza Bawa-Garba should be reinstated on the UK medical register. The Court of Appeal rejected...
Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.Myasthenia gravis presenting with isolated ptosis: a poorly studied subgroup
1 February 2015
| B Karri, RT Sebastian, G Kyle, IK Hart
|
EYE - Vitreo-Retinal
Investigation into the cause of one isolated symptom or sign can be challenging if that particular sign may be caused by a variety of pathological processes, affecting different tissues, and presenting to different specialties. Unilateral ptosis is a case in...
Protecting and recovering from email hacking
1 February 2016
| David Haider
Over the last 12 months I have received emails from more than 20 friends and acquaintances (mostly doctors) who didn’t send those emails. More often than not I find the emails in my ‘Spam’ folder as Gmail knows they are...
Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice
1 February 2015
| Pearse A Keane (Prof), Adnan Tufail
|
EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...
Broadening of treatment options for potentially blinding retinal conditions
2 August 2022
| Rod McNeil
|
EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...
Outcomes of primary and repeat DSAEKs
Retrospective analysis of results following primary and secondary descemet stripping automated endothelial keratoplasty (DSAEKs), carried out in Villa Serena-Villa Igea Private Hospitals in Italy, showed that primary and secondary DSAEK surgery result in similar visual outcomes, refractive errors and endothelial...
Systemic anti-inflammatory versus fluocinolone acetonide intraocular implant
1 February 2016
| Brian Ang
|
EYE - Vitreo-Retinal
In the Multicenter Uveitis Steroid Treatment (MUST) trial, 255 patients with intermediate uveitis, posterior uveitis or panuveitis were randomised to either fluocinolone acetonide intraocular implant or systemic corticosteroid therapy which was supplemented with immunosuppression if required. Patients were followed up...
